These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 26121320

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: difference between puromycin aminonucleoside and adriamycin nephrosis.
    Ginevri F, Gusmano R, Oleggini R, Acerbo S, Bertelli R, Perfumo F, Cercignani G, Allegrini S, D'Allegri F, Ghiggeri G.
    Clin Sci (Lond); 1990 Mar; 78(3):283-93. PubMed ID: 2156648
    [Abstract] [Full Text] [Related]

  • 23. The immunosuppressive drug mizoribine directly prevents podocyte injury in puromycin aminonucleoside nephrosis.
    Takeuchi S, Hiromura K, Tomioka M, Takahashi S, Sakairi T, Maeshima A, Kaneko Y, Kuroiwa T, Nojima Y.
    Nephron Exp Nephrol; 2010 Mar; 116(1):e3-10. PubMed ID: 20502051
    [Abstract] [Full Text] [Related]

  • 24. Reduced sialylation of podocalyxin--the major sialoprotein of the rat kidney glomerulus--in aminonucleoside nephrosis.
    Kerjaschki D, Vernillo AT, Farquhar MG.
    Am J Pathol; 1985 Mar; 118(3):343-9. PubMed ID: 3976840
    [Abstract] [Full Text] [Related]

  • 25. Glomerular epithelial detachment, not reduced charge density, correlates with proteinuria in adriamycin and puromycin nephrosis.
    Whiteside C, Prutis K, Cameron R, Thompson J.
    Lab Invest; 1989 Dec; 61(6):650-60. PubMed ID: 2601299
    [Abstract] [Full Text] [Related]

  • 26. Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat.
    Holthöfer H, Reivinen J, Solin ML, Haltia A, Miettinen A.
    Am J Pathol; 1996 Sep; 149(3):1009-15. PubMed ID: 8780404
    [Abstract] [Full Text] [Related]

  • 27. A scanning and transmission electron microscopic comparison of puromycin aminonucleoside-induced nephrosis to hyperalbuminemia-induced proteinuria with emphasis on kidney podocyte pedicel loss.
    Andrews PM.
    Lab Invest; 1977 Feb; 36(2):183-97. PubMed ID: 839733
    [Abstract] [Full Text] [Related]

  • 28. Role of Fat1 in cell-cell contact formation of podocytes in puromycin aminonucleoside nephrosis and neonatal kidney.
    Yaoita E, Kurihara H, Yoshida Y, Inoue T, Matsuki A, Sakai T, Yamamoto T.
    Kidney Int; 2005 Aug; 68(2):542-51. PubMed ID: 16014031
    [Abstract] [Full Text] [Related]

  • 29. GLEPP1 receptor tyrosine phosphatase (Ptpro) in rat PAN nephrosis. A marker of acute podocyte injury.
    Kim YH, Goyal M, Wharram B, Wiggins J, Kershaw D, Wiggins R.
    Nephron; 2002 Apr; 90(4):471-6. PubMed ID: 11961407
    [Abstract] [Full Text] [Related]

  • 30. Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro.
    Zheng CX, Chen ZH, Zeng CH, Qin WS, Li LS, Liu ZH.
    Kidney Int; 2008 Sep; 74(5):596-612. PubMed ID: 18509322
    [Abstract] [Full Text] [Related]

  • 31. Effects of human alpha-1-acid glycoprotein on aminonucleoside-induced minimal change nephrosis in rats.
    Muchitsch E, Pichler L, Schwarz HP, Ulrich W.
    Nephron; 1999 Feb; 81(2):194-9. PubMed ID: 9933755
    [Abstract] [Full Text] [Related]

  • 32. Ultrastructural study on nephrin expression in experimental puromycin aminonucleoside nephrosis.
    Lee YK, Kwon T, Kim DJ, Huh W, Kim YG, Oh HY, Kawachi H.
    Nephrol Dial Transplant; 2004 Dec; 19(12):2981-6. PubMed ID: 15385636
    [Abstract] [Full Text] [Related]

  • 33. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
    Nakayama K, Natori Y, Sato T, Kimura T, Sugiura A, Sato H, Saito T, Ito S, Natori Y.
    J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
    [Abstract] [Full Text] [Related]

  • 34. Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis.
    Inokuchi S, Shirato I, Kobayashi N, Koide H, Tomino Y, Sakai T.
    Kidney Int; 1996 Oct; 50(4):1278-87. PubMed ID: 8887289
    [Abstract] [Full Text] [Related]

  • 35. Permeability, ultrastructural changes, and distribution of novel proteins in the glomerular barrier in early puromycin aminonucleoside nephrosis.
    Dunér F, Lindström K, Hultenby K, Hulkko J, Patrakka J, Tryggvason K, Haraldsson B, Wernerson A, Pettersson E.
    Nephron Exp Nephrol; 2010 Oct; 116(2):e42-52. PubMed ID: 20588063
    [Abstract] [Full Text] [Related]

  • 36. Experimentally induced puromycine aminonucleoside nephrosis (PAN) in rats: evaluation of angiogenic protein platelet-derived endothelial cell growth factor (PD-ECGF) expression in glomeruli.
    Seckin I, Uzunalan M, Pekpak M, Kokturk S, Sonmez H, Oztürk Z, Demirci S, Yaprak E.
    J Biomed Sci; 2012 Feb 16; 19(1):24. PubMed ID: 22335899
    [Abstract] [Full Text] [Related]

  • 37. Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats.
    Matsui I, Hamano T, Tomida K, Inoue K, Takabatake Y, Nagasawa Y, Kawada N, Ito T, Kawachi H, Rakugi H, Imai E, Isaka Y.
    Nephrol Dial Transplant; 2009 Aug 16; 24(8):2354-61. PubMed ID: 19297354
    [Abstract] [Full Text] [Related]

  • 38. Dual effects of lisinopril on puromycin aminonucleoside nephrosis in unilaterally nephrectomized rats.
    Shinosaki T, Takagawa I, Sunagawa N, Yonetani Y, Kurihara H.
    Jpn J Pharmacol; 1997 Apr 16; 73(4):337-45. PubMed ID: 9165371
    [Abstract] [Full Text] [Related]

  • 39. Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats.
    Ricardo SD, Bertram JF, Ryan GB.
    J Am Soc Nephrol; 1994 Jun 16; 4(12):1974-86. PubMed ID: 7919151
    [Abstract] [Full Text] [Related]

  • 40. Antiproteinuric effect of an endothelin-1 receptor antagonist in puromycin aminonucleoside-induced nephrosis in rat.
    Kino J, Tsuji S, Kitao T, Akagawa Y, Yamanouchi S, Kimata T, Kaneko K.
    Pediatr Res; 2018 May 16; 83(5):1041-1048. PubMed ID: 29360807
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.